Validity and Reliability of the Reflux Sign Assessment‐10 ( RSA ‐10)
The Laryngoscope · 2024
DOI: 10.1002/lary.31420 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift The Laryngoscope, 2024. Verfasst von Jérôme R Lechien und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Committee of the Young-Otolaryngologists of the International Federations of Oto-rhino-laryngological Societies (YO-IFOS), Paris, France. Hauptthemen laut MEDLINE: Laryngopharyngeal Reflux, Esophageal pH Monitoring. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Roi Baudouin Foundation.
Abstract (Originalsprache)
Objective
To develop and validate the Reflux Sign Assessment‐10 (RSA‐10) for documenting the physical findings of laryngopharyngeal reflux disease (LPRD).
Methods
Patients with LPRD at the hypopharyngeal‐esophageal multichannel intraluminal impedance‐pH monitoring and asymptomatic individuals were consecutively recruited from two European hospitals. Three experienced otolaryngologists rated RSA‐10 in patients and controls for assessing internal validity. RSA‐10 was rated within a 7‐day period to assess test‐retest reliability. Internal consistency was measured using Cronbach's α in patients and controls. Convergent validity was evaluated through a correlation analysis between RSA‐10 and Reflux Finding Score (RFS). Interrater reliability was evaluated by comparing the RSA‐10 evaluations of the three otolaryngologists through Fleiss kappa. Pre‐ to posttreatment change of RSA‐10 was evaluated to assess responsiveness to change. The RSA‐10 thresholds were examined by receiver operating characteristic analysis.
Results
Fifty‐five patients completed the pre‐ to posttreatment evaluations from January 2020 to December 2023. A total of 115 asymptomatic individuals completed the study. RSA‐10 reported high internal consistency reliability ( α = 0.822) and test‐retest reliability ( r s = 0.725). The RSA‐10 scores of patients were significantly higher than those of controls ( p = 0.001), suggesting high internal validity. RSA‐10 was significantly correlated with the RFS ( r s = 0.771). The interrater reliability was adequate for sub‐ and total RSA‐10 scores ( k = 0.708). RSA‐10 significantly improved from baseline to 3‐month posttreatment ( p = 0.001). An RSA‐10 > 13 may be suggestive of LPRD. Both RSA‐10 > 13 and Reflux Symptom Score‐12 > 11 were associated with a sensitivity of 92.7% and a specificity of 97.3%.
Conclusion
The RSA‐10 is a reliable and valid clinical instrument for documenting the most prevalent laryngeal and extra‐laryngeal findings associated with LPRD. Level of Evidence 3 Laryngoscope , 134:3981–3988, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research Committee of the Young-Otolaryngologists of the International Federations of Oto-rhino-laryngological Societies (YO-IFOS), Paris, France.
- Division of Laryngology and broncho-esophagology, Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, B…
- Department of Otorhinolaryngology and Head and Neck Surgery, CHU Saint-Pierre, Brussels, Belgium.
- Department of Otolaryngology-Head & Neck Surgery, Foch Hospital, Paris Saclay University, Paris, France.
- Department of Otorhinolaryngology and Head and Neck Surgery, CHU de Liège (Sart Tilman), Liège, Belgium.
ORCID-Profile: Jérôme R Lechien
Förderung
- Roi Baudouin Foundation
Zitieren
APA
Lechien, J. R., De Marrez, L. G., Finck, C., & Saussez, S. (2024). Validity and Reliability of the Reflux Sign Assessment‐10 ( RSA ‐10). The Laryngoscope. https://doi.org/10.1002/lary.31420
Vancouver
Lechien JR, De Marrez LG, Finck C, Saussez S. Validity and Reliability of the Reflux Sign Assessment‐10 ( RSA ‐10). The Laryngoscope. 2024. doi:10.1002/lary.31420
BibTeX
@article{Lechien2024,
author = {Lechien, Jérôme R and De Marrez, Lisa G and Finck, Camille and Saussez, Sven},
title = {Validity and Reliability of the Reflux Sign Assessment‐10 ( RSA ‐10)},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31420}
}
EUVIMED